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PURPOSE. Noncoding microRNAs (miRNAs) have been implicated in the pathogenesis of
glaucoma. We aimed to identify common variants in miRNA coding genes (MIR) associated
with primary open-angle glaucoma (POAG).
METHODS. Using the NEIGHBORHOOD data set (3853 cases/33,480 controls with European
ancestry), we first assessed the relation between 85 variants in 76 MIR genes and overall
POAG. Subtype-specific analyses were performed in high-tension glaucoma (HTG) and
normal-tension glaucoma subsets. Second, we examined the expression of miR-182, which
was associated with POAG, in postmortem human ocular tissues (ciliary body, cornea, retina,
and trabecular meshwork [TM]), using miRNA sequencing (miRNA-Seq) and droplet digital
PCR (ddPCR). Third, miR-182 expression was also examined in human aqueous humor (AH)
by using miRNA-Seq. Fourth, exosomes secreted from primary human TM cells were
examined for miR-182 expression by using miRNA-Seq. Fifth, using ddPCR we compared miR-
182 expression in AH between five HTG cases and five controls.
RESULTS. Only rs76481776 in MIR182 gene was associated with POAG after adjustment for
multiple comparisons (odds ratio [OR] ¼ 1.23, 95% confidence interval [CI]: 1.11–1.42, P ¼
0.0002). Subtype analysis indicated that the association was primarily in the HTG subset (OR
¼ 1.26, 95% CI: 1.08–1.47, P ¼ 0.004). The risk allele T has been associated with elevated
miR-182 expression in vitro. Data from ddPCR and miRNA-Seq confirmed miR-182 expression
in all examined ocular tissues and TM-derived exosomes. Interestingly, miR-182 expression in
AH was 2-fold higher in HTG patients than nonglaucoma controls (P ¼ 0.03) without
controlling for medication treatment.
CONCLUSIONS. Our integrative study is the first to associate rs76481776 with POAG via elevated
miR-182 expression.
Keywords: miR-182, POAG, genetic association, NEIGHBORHOOD, exosome
Glaucoma, a heterogeneous group of disorders with manydifferent subtypes, is a leading cause of irreversible
blindness affecting more than 60 million individuals world-
wide.1–3 Primary open-angle glaucoma (POAG) is the most
common type and has a complex inheritance pattern.3 It is
defined by a characteristic pattern of progressive retinal
ganglion cell death, optic nerve head excavation, and visual
field loss. Known risk factors for POAG include advanced age,
elevated intraocular pressure (IOP), family history of glaucoma,
African ancestry, and genetic factors.3 Family-based linkage
studies and case-control association studies have identified a
large number of genomic loci with mutations and genetic
variants associated with POAG or glaucoma-related ocular
phenotypes, such as elevated IOP, increased cup-to-disc ratio,
and reduced central cornea thickness (see reviews1,4,5).
Besides the genetic factors, microRNAs (miRNAs) also play
important roles in the pathogenesis of POAG. These miRNAs
are encoded by MIR RNA genes. For example, miR-183 targets
integrin-b1 and affects trabecular meshwork (TM) physiology.6
Regulated by TGF-b2, miR-29b modulates the expression of
extracellular matrix genes, which function in the aqueous
outflow pathway.7,8 Induced miR-24 expression in the TM by
cyclic mechanic stress downregulates FURIN and TGF-b1, of
which higher expression levels lead to elevated IOP.9 A number
of miRNAs, such as miR-204, miR-200c, miR-182, and miR-183,
are differentially expressed in human TM cells in stress-induced
senescence or replicative senescence.10,11 miR-200c inhibits
the contraction of TM cells and reduces IOP in living rats,
while inhibition of miR-200c in rats leads to a robust IOP
increase.12 To further understand the role of miRNAs in POAG,
it will be necessary to identify the genetic factors that regulate
miRNA expression in ocular tissues.
Sequence alterations in MIR genes encoding miRNAs have
been previously associated with many human disorders.13
Mutations of miRNA genes have been identified in a number of
diseases, such as keratoconus with congenital cataract
(MIR184) and progressive hearing loss (MIR96).14–16 Variants
in the seed region of miR-125a impact not only its mediated
translational suppression, but also its biogenesis—processing
from pri–miR-125a to pre–miR-125a.17 Variants in several MIR
genes have been associated with uveitis in Chinese popula-
tions.18,19 To determine the role of MIR genes in POAG, we
performed a candidate variant association analysis with
common single nucleotide polymorphisms (SNPs) within
MIR genes in a large POAG consortium case-control data set
with European ancestry. Association analysis was followed by
gene expression and differential expression analysis in human
ocular tissues and aqueous humor samples.
METHODS
Study Population
Our research adhered to the tenets of the Declaration of
Helsinki and was Health Insurance Portability and Account-
ability Act (HIPAA)-compliant. Institutional Review Board
(IRB)/Ethics Committee approval was obtained at the Medical
College of Georgia and all the participating institutions
involved in the NEIGHBORHOOD (National Eye Institute
Glaucoma Human Genetics Collaboration Heritable Overall
Operational Database) consortium. Written informed consent
was obtained from all participating individuals. Our study
used the NEIGHBORHOOD consortium containing eight data
sets: Iowa, NEIGHBOR, MEEI, OHTS, Marshfield, Nurses’
Health Study (NHS)/Health Professionals Follow-up Study
(HPFS) Affymetrix, NHS/HPFS Illumina, and Women’s Ge-
nome Health Study (WGHS).20 Details of these eight data sets
and the definition of POAG have been described previously.20
NEIGHBORHOOD includes 3853 POAG cases and 33,480
controls with European ancestry from the United States.
Primary open-angle glaucoma was defined as characteristic
visual field defects consistent with glaucomatous optic
neuropathy. Elevated IOP (>21 mm Hg) was not used as a
criterion for POAG. Primary open-angle glaucoma cases were
classified as either high-tension glaucoma (HTG) (maximum
IOP > 21 mm Hg) or normal-tension glaucoma (NTG)
(maximum IOP " 21 mm Hg) when data on maximum IOP
were available.20
Association of miR-182 and POAG in NEIGHBORHOOD IOVS j August 2016 j Vol. 57 j No. 10 j 4529
Genotype imputation was done by using IMPUTE2 or
MACH with the 1000Genomes Project Reference panel (March
2012), and quality control was done for each data set as
previously described.20 Principal components were computed
for all participants by using EIGENSTRAT. For each data set,
logistic regression analysis was performed with ProbABEL for
all analyses (POAG overall, HTG, NTG, POAG among males
only, and POAG among females only), with the adjustment for
age, sex, and any significant eigenvectors from principal
components analysis. METAL was used for a meta-analysis of
the estimated genotypic probabilities for all 6,425,680 variants
as previously described.20
Meta-analysis of MIR-Related Sequence Variants
Table Browser in the UCSC Genome Browser was used to
identify a list of genomic coordinates for all known miRNA
genes in the human genome, based on the GRCh37/hg19 build.
Using dbSNP version 141, a list of common SNPs with minor
allele frequency (MAF) > 0.01 was then created, covering all
genomic regions of MIR genes, including precursors and seed
regions of miRNAs. The MAF was calculated in the general
population. A total of 253 common SNPs are located in the
autosomal chromosomes (Supplementary Table S1), of which
138 SNPs have MAF greater than 0.05, meeting the minimum
MAF cutoff for imputed SNPs in the NEIGHBORHOOD data set.
Overlap between these 138 SNPs and the imputed SNPs in
NEIGHBORHOOD analysis was examined, indicating that 85
SNPs were available in the NEIGHBORHOOD. The genetic
analysis included association with POAG overall, two subtype
analyses (NTG and HTG), and two stratified analyses (POAG
among males, and POAG among females). Eighty-five SNPs in
76 MIR genes were included in the NEIGHBORHOOD meta-
analysis with POAG overall in all eight data sets (Supplemen-
tary Table S2). Sex-stratified and subtype analyses for NTG and
HTG were performed by using the controls from each related
data set. Although this is a genome-wide analysis for MIR-
related SNPs, only 85 statistical comparisons were performed,
rendering a stringent P value cutoff of 5.88310#4 (0.05/85) for
significant associations.
miRNA Sequencing
miRNA sequencing (miRNA-Seq) was performed as previously
described.21,22 Briefly, human ocular tissues including two
corneal (53-year old female and 49-year old male), two ciliary
body (CB) (67-year-old male and 72-year-old female), two
retinal (72-year-old female and 59-year-old female), and four
trabecular meshwork (TM) samples (77-year-old male, 67-year-
old female, 59-year-old female, and 61-year-old female) were
obtained from 10 postmortem eyes donated by healthy
individuals with no history of ocular diseases, within 24 hours
of death as described previously.23 Total RNA was extracted by
using mirVana miRNA Isolation kit from Life Technologies
(Carlsbad, CA, USA) according to the standard protocol. After
quality and quantity check, 1 lg total RNA was used to
generate the small RNA sequencing library using the TruSeq
Small RNA Sample Prep kit from Illumina (San Diego, CA, USA)
according to the standard protocol. Sequencing was performed
with Illumina MiSeq, using the MiSeq Reagent kit v2 with 50
cycles. Sequencing reads for all 10 samples were analyzed as
previously described.22 The expression level for each miRNA
was normalized as the number of sequence reads per million of
total sequencing reads for each tissue with Microsoft Excel
2013 (Microsoft Corp., Seattle, WA, USA) and the R Language
and Environment for Statistical Computing.24 The expression
levels of miR-182 were examined in these 10 ocular samples.
miR-182 Expression in Human Ocular Tissues
To examine the expression of miR-182 in human ocular
tissues, we determined miR-182 expression in eight postmor-
tem human ocular samples from four tissues (two CB, two
corneal, 2 retinal, and two TM samples) by using droplet
digital polymerase chain reaction (ddPCR). RNA from the
tissues was prepared by using the same method described
above.23 Droplet digital PCR was performed by using the
QX200 Droplet Digital PCR system from Bio-Rad (Hercules,
CA, USA) as described previously.25 TaqMan miRNA assay for
miR-182 (Cat No. 4427975, Assay ID 002234) was obtained
from Applied Biosystems (Grand Island, NY, USA). To perform
the ddPCR, approximately 20 ng total RNA of each sample
was reverse transcribed to cDNA with TaqMan microRNA
Reverse Transcriptase kit from Applied Biosystems according
to the manufacturer’s instructions. Droplet digital PCR was
performed by using QX200 ddPCR Supermix for Probes (no
dUTP) from Bio-Rad. The amplified PCR products were
quantified by using Bio-Rad QX200 droplet reader and
analyzed by the QuantaSoft software. For quality control,
PCR reactions with fewer than 10,000 droplets were
excluded, and negative controls containing water instead of
cDNA were included to ensure no contamination in all
reagents.
Characterization of Exosomes and miRNAs
Derived From Primary Human TM
Human TM (HTM) cells were isolated from donor eyes by using
a blunt dissection technique and then the extracellular matrix
digestion protocol. Cell strains were characterized as previ-
ously described.26 Cells were grown in low-glucose Dulbecco’s
modified Eagle’s medium, containing 1% exosome-depleted
fetal bovine serum (FBS), 100 U/mL penicillin, 0.1 mg/mL
streptomycin, and 0.29 mg/mL glutamine with 5% CO2 at 378C.
Cells were serum starved overnight before exosome collection.
Culture media was replaced with fresh serum-free media, and
cells were allowed to condition the media for 2.5 hours.
Conditioned media was centrifuged at 300g for 10 minutes at
48C, followed by 10,000g for 40 minutes at 48C. The resulting
supernatant was then spun at 100,000g for 70 minutes at 48C
in an SW28 rotor (Beckman Coulter, Inc., Indianapolis, IN,
USA), and the pellet was resuspended with PBS. This solution
was spun again at 100,000g for 70 minutes at 48C in an SW28
rotor. The supernatant was removed, and the pellet resus-
pended in PBS. The concentration and size distribution of the
prepared vesicles were determined by using nanoparticle
tracking analysis (NanoSight NS500, Malvern, Inc., Malvern,
United Kingdom) as previously described.22 Three separate
measurements were performed for the isolated exosomes, and
the average of these measurements was used in the analysis.
Exosomal RNA was extracted with the miRCURY RNA Isolation
kit (Exiqon, Woburn, MA, USA) according to the recommended
procedure.22 miRNA-Seq was performed as previously de-
scribed.21,22 After miRNA-Seq, the expression of miR-182 was
examined in these exosomes.
miR-182 Expression in Aqueous Humor (AH) From
Glaucoma Patients and Normal Controls
Human AH samples (~100 lL per individual) were collected at
Vanderbilt University Medical Center with protocols approved
by Vanderbilt University IRB. All samples were collected by a
single surgeon (RWK) using consistent techniques described
previously.27 Our study for ddPCR included AH from five HTG
cases and five controls. The mean age was 64.4 6 9.7 years for
controls (48, 64, 67, 71, and 72 years individually) and 73.6 6
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7.0 years for cases (64, 71, 72, 80, and 81 years individually).
All 10 donors were of European descent, with three male/two
female controls and five female cases. Total RNA was extracted
by using the miRCURY RNA Isolation kit according to the
standard procedure. To perform the ddPCR, 3 lL of 50 lL total
RNA from each sample was used to perform ddPCR as
described above. The absolute copies of miR-182 were
measured in all 10 AH samples. Since the same volume of
extracted RNA was used for all 10 AH samples, the absolute
copies of miR-182 were compared between the control and
POAG groups by using Student’s t-test. No specific covariates,
such as age or sex, were included in the test.
RESULTS
Genetic Association With POAG
Our study included a total of 3853 POAG cases and 33,480
controls from the NEIGHBORHOOD consortium (Table 1).
Among POAG, we classified 725 cases as NTG and 1868 cases
as HTG, while the remaining 1260 cases were not classifiable
owing to limited available information. This consortium
included 1691 male and 2160 female POAG cases as well as
4367 male and 29,111 female controls.
Eighty-five SNPs were successfully included in the NEIGH-
BORHOOD meta-analysis after quality control (Supplementary
Table S2). Only one SNP rs76481776 located in MIR182 gene
was significantly associated POAG (P¼ 0.0002, odds ratio [OR]
¼ 1.23, 95% confidence interval [CI]: 1.11–1.42; Table 2). This
SNP was also nominally significant in the subgroup analyses of
HTG (P¼ 0.004, OR¼ 1.26, 95% CI: 1.08–1.47), but not NTG
(P ¼ 0.13, OR ¼ 1.21, 95% CI: 0.94–1.54). This SNP was also
nominally significant in male POAG cases (P ¼ 0.007, OR ¼
1.31, 95% CI: 1.08–1.60) and female POAG cases (P ¼ 0.005,
OR ¼ 1.24, 95% CI: 1.07–1.45). It is noted that the stratified
associations with HTG or sex were not significant after
correction for multiple comparisons. The frequency of T allele
was 0.05 in controls and 0.08 in POAG cases.
miRNA Expression in Human Ocular Tissues
Our miRNA-Seq in normal human ocular tissue successfully
identified the expression of many miRNAs, including miR-182
(Fig. 1A). miR-182 was highly expressed in all four ocular
tissues tested. Our ddPCR assay successfully validated the
expression of miR-182 in normal human retinal, corneal, CB,
and TM tissues (Fig. 1B), with the highest expression in retina.
Since the association of SNP rs76481776 appears to be
specifically associated with HTG, we also examined the
expression of miR-182 in human AH. We have shown
previously that AH has miRNA-containing exosomes.22 Our
miRNA-Seq data from pooled nonglaucoma human AH samples
indicated miR-182 expression with five reads per million
sequencing reads, suggesting a relatively low expression of
miR-182 in nonglaucoma human AH.
TABLE 1. The Number of Individuals From the NEIGHBORHOOD Data
Set
No. Cases No. Controls
NEIGHBORHOOD 3853 33,480
High-tension glaucoma 1868 31,497
Normal-tension glaucoma 725 11,145
Male 1691 4367
Female 2160 29,111
NEIGHBORHOOD, National Eye Institute Glaucoma Human Genet-
ics Collaboration Heritable Overall Operational Database.
TABLE 2. Association of rs76481776 in MIR182 in the NEIGHBORHOOD Data Set
POAG8 NTG4 HTG6 Male7 Females8
P value 0.00020 0.13 0.0038 0.0070 0.0050
OR 1.23 1.21 1.26 1.31 1.24
95% CI 1.11–1.42 0.94–1.54 1.08–1.47 1.08–1.60 1.07–1.45
Direction #þþ#þþþþ þþþþ #þþþþþ þþþþþþþ þ##þ#þþþ
Symbols 6 refer to the direction of effect of the reference allele (A1) where þ indicates a variant is associated in the positive direction, #
indicates it is associated in the negative direction. Order of data sets in POAG8 and Females8: Iowa, NEIGHBOR, MEEI, OHTS, Marshfield, NHS/HPFS
Affymetrix, NHS/HPFS Illumina, and WGHS; order of data sets for NTG4: NEIGHBOR, MEEI, NHS/HPFS Affymetrix, NHS/HPFS Illumina; order of
data sets for HTG6: OHTS, NEIGHBOR, MEEI, NHS/HPFS Affymetrix, NHS/HPFS Illumina, WGHS; order of data sets for Male7: Iowa, NEIGHBOR,
MEEI, OHTS, Marshfield, NHS/HPFS Affymetrix, NHS/HPFS Illumina. NEIGHBORHOOD, National Eye Institute Glaucoma Human Genetics
Collaboration Heritable Overall Operational Database.
FIGURE 1. Expression of miR-182 in four different normal ocular
tissues with miRNA sequencing (A) and ddPCR (B), including CB,
cornea, retina, and TM. miRNA-Seq was done with two CB, two
corneal, two retinal, and four TM samples, while ddPCR was done with
two CB, two corneal, two retinal, and two TM samples.
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miR-182 Expression in HTM-Derived Exosomes
Because of the critical role of TM in aqueous outflow pathway,
we isolated and characterized the exosomes from human
primary nonglaucoma TM cells by using nanoparticle tracking
analysis (Fig. 2). The data shown in Figure 2 were the average
of three separate measurements of HTM-derived exosomes.
The diameter (the most abundant peak) was 82 nm and the
concentration of isolated exosomes was 2.87 3 108 particles/
mL with 1:500 dilution, therefore with an original concentra-
tion of 1.44 3 1011 particles/mL. After extracting RNA from
these exosomes, our miRNA-Seq data indicated the expression
of miR-182 in the HTM-derived exosomes as four read counts
per million sequencing reads, suggesting a relatively low
expression level in exosomes from nonglaucoma HTM cells.
Differential Expression Analysis in Glaucoma
Using five nonglaucoma and five glaucoma AH samples, we
checked the differential expression of miR-182 using ddPCR.
We have found that although the relative expression of miR-
182 in human AH was low, the absolute expression of miR-182
in AH from patients with HTG was significantly elevated by 2-
fold (P ¼ 0.03; Fig. 3).
DISCUSSION
For the first time, using the comprehensive NEIGHBORHOOD
data set, we have identified a significant association of
rs76481776 in MIR182 gene with POAG, especially with the
HTG subset. We have confirmed the expression of miR-182 in
several normal human ocular tissues including AH, as well as
miRNA-containing exosomes derived from human primary TM
cells. Our study also indicated the significantly elevated
expression of miR-182 in AH samples from HTG patients
compared to those from unaffected controls. Both genetic
association and differential expression data indicated the
potential contribution of miR-182 in the pathogenesis of POAG.
Although we identified 138MIR-related common SNPs, only
85 SNPs were included in our final analysis. The lack of
coverage on the excluded 53 common SNPs could be due to
several reasons. First, these common SNPs may not be tagged
by the available genotyped SNPs on the selected Illumina/
Affymetrix arrays. Second, some of these SNPs may have been
removed during the quality control (MAF ‡ 0.05, imputation
quality score [r2] ‡ 0.7, presence of SNPs in at least two
studies, and effect estimate jbj " 5) after imputation. Third, the
actual observed MAF frequency in NEIGHBORHOOD data sets
might be lower than 0.05. Lastly, it could be that the MAF from
dbSNP141 was based on non-Caucasian populations.
Interestingly, the minor T allele of this variant rs76481776,
which is associated with increased risk of POAG, has been
shown to increase the expression of mature miR-182 in vitro by
30%.28 Our genetic association suggests that elevated expres-
sion of miR-182 might underlie the increase in glaucoma risk.
Our differential expression analysis with human AH confirmed
the significantly 2-fold elevated expression in HTG patients.
Since all of the HTG patients were treated with antiglaucoma
medications at the time of AH collection, we could not rule out
medication effect on the observed differentiation expression of
miR-182. In addition, all five HTG cases were females, while
the controls included two females and three males. Owing to
the limited access to AH from HTG patients, determining the
cause of elevated miR-182 expression in AH remains a
challenge. As our expression data indicated, miR-182 is highly
expressed in cornea, CB, and TM; it will be difficult to
determine which ocular tissue directly contributes to the
increased miR-182 expression in AH of glaucoma patients.
Previous research from Li and colleagues10 has revealed that
miR-182 expression is upregulated by 7- to 9-fold in primary
HTM cells with stress-induced premature senescence and that
miR-182 overexpression in these HTM cells may contribute to
the phenotypic alterations of senescent cells. These miR-182
expression findings are consistent with our observation of
elevated expression of miR-182 in POAG, suggested by both
genetic association and differential AH expression. The
elevated expression of miR-182 in TM cells may contribute to
potential TM cellular dysfunction, such as cell contractility
and/or phagocytosis ability. Additional studies are necessary to
verify this hypothesis.
The specific variant rs76481776 in MIR182 gene has been
associated with several other human genetic disorders, such as
late insomnia of major depression, Behc¸et’s disease, and Vogt-
Koyanagi-Harada syndrome.18,28 Both studies18,28 identified the
FIGURE 2. Nanoparticle tracking analysis (size and concentration) of
exosomes derived from primary human nonglaucoma trabecular
meshwork cells, using NanoSight NS500 system. The exosome sample
was resuspended in 1X PBS and diluted by 1:500 with PBS. Three
separate measurements were performed to calculate the mean, which
were used to derive this figure.
FIGURE 3. Differential expression of miR-182 in human aqueous
humor samples from nonglaucoma controls (n¼ 5) and HTG patients
(n ¼ 5). The absolute copy numbers of miR-182 in each sample was
measured by using ddPCR. All POAG patients were female, while
controls included 3 males and 2 females. The males in the control
group were marked with the black arrow.
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same associated risk allele T with elevated expression of miR-
182 in individuals with homozygotes of T allele. Elevated miR-
182 expression may reduce the expression of several circadian
rhythm–related genes such as ADCY6, CLOCK, and DISP,
which regulates the endogenous circadian clock.28,29
Owing to its high expression in retina, miR-182 has been
previously evaluated for a role in retinal disease. Conditional
knockout of miR-182 in the mouse has shown no apparent
structural retinal abnormalities with either heterozygotes or
homozygotes after 1 year of age.30 Additional work indicates
that miR-182, together with miR-183 and miR-96, may be
necessary for cone outer segment maintenance, functional
outer segment formation,31 acute light-induced retinal degen-
eration in mice,32 and postnatal functional differentiation and
synaptic connectivity of photoreceptors.33 However, miR-182’s
potential function in the anterior chamber tissues has not been
previously evaluated. Our study suggests that expression of
miR-182 is altered in glaucoma patients and that variation in
expression could contribute to glaucoma development.
Additional research including transgenic mouse models will
be necessary to explore the specific role of miR-182 in IOP
regulation and AH dynamics.
miR-182, depending on the type of cell and tissue, may
affect the expression of many target genes involved in different
pathways, such as DNA repair, cell cycle, phototransduction,
apoptotic pathway, cell proliferation, cell migration, response
to oxidative stress, and vesicle organization.10,28,31–36 Among
these target genes, sequencing variants in CHEK2 (checkpoint
kinase 2) gene have been associated with vertical cup-to-disc
ratio and HTG.37,38 Another target FOXO1 is required for
proper lymphatic vascular development.39 Variants in or near
FOXO1 have recently been associated with central cornea
thickness, which is a risk factor for glaucoma.40–42 On the
other hand, FOXO1, as a direct target of FOXC1, is involved in
maintaining the cellular homeostasis and resistance to oxida-
tive stress in the eye, while FOXC1 sequence variants have
been associated with POAG.20,43–46 Other validated target
genes of miR-182 include profilin 1 (PFN1), metastasis
suppressor 1 (MTSS1), microphthalmia-associated transcrip-
tion factor (MITF), and reversion-inducing-cysteine-rick protein
with Kazal motifs (RECK).47–50 In human cancer TGF-b may
induce miR-182 expression, which suppresses cylindromatosis
expression (CYLD, an NF-jB–negative regulator), leading to
prolonged NF-jB activation.51 Interestingly, TGF-b–related
pathways have been shown to play important roles in the
pathogenesis of POAG and fibrosis.52 The exact mechanism or
targets associated with elevated miR-182 expression in relation
to HTG remain unknown.
Our study had several limitations. First, although our
NEIGHBORHOOD consortium is the largest POAG case-control
data set currently available worldwide, additional genetic
studies replicating the genetic association of MIR182 variant
with HTG will help confirm these findings. Since our
association included only subjects with European ancestry,
studies with other ethnicities will be necessary. Second, our
human AH–based expression study is relatively small and is
confounded by use of medications. Third, owing to the lack of
genotype information from the donors, our study did not
examine the correlation of miR-182 expression with different
genotypes of the HTG-associated variant (rs76481776). It
would be interesting to examine the miR-182 levels in AH
from HTG patients with homozygous risk T alleles and controls
with homozygous T alleles.
In summary, we identified a significant association between
miR-182 and POAG, especially in HTG individuals. The high-
level expression of miR-182 in glaucoma-associated ocular
tissues and its elevated expression in AH from HTG patients
and human TM-derived exosomes further support the potential
contribution of miR-182 in POAG pathogenesis through
regulation of AH dynamics and IOP. Further studies may
identify miR-182 targets for novel therapies for POAG.
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